Picard Medical Inc

This proposal requests a non-binding, advisory approval (Say-on-Pay) of the company’s overall executive compensation as disclosed in the proxy, asking shareholders to affirm the compensation committee’s approach to pay design. Management frames the program as intended to attract, motivate and retain executives while aligning their interests with stockholders and enabling the achievement of short- and long-term business goals; it emphasizes benchmarking to industry and market practices. The advisory nature means the Board and compensation committee retain discretion, but they state they will consider the vote’s outcome when reviewing future compensation actions, signaling responsiveness to investor sentiment. The proposal does not target any specific element of pay, but encompasses base salary, annual cash bonuses, long-term equity incentives (notably large option grants and plan mechanics), and benefits outlined under “Executive Compensation.” Key governance considerations include the company’s adoption of a clawback policy, equity incentive plan adjustments, and potential change-of-control vesting protections. For investors, the vote serves as a signal regarding perceived pay-for-performance alignment, particularly given the company’s recent financial losses and significant related-party financings which raise scrutiny over governance and compensation prudence. The Board recommends a FOR vote, arguing the program supports retention and alignment; however, investors should weigh the advisory outcome against the company’s capital structure changes and historical related-party transactions. While the vote is non-binding, a materially adverse result could lead to engagement and changes by the compensation committee, making it an important governance indicator for sophisticated investors assessing executive incentives relative to company performance and shareholder dilution risk.

This advisory proposal asks shareholders to select their preferred frequency (1, 2, or 3 years) for future non-binding Say-on-Pay votes; unlike the substantive Say-on-Pay vote, it addresses cadence of shareholder input. Management supports annual votes, arguing that yearly advisory input offers timely feedback and greater accountability for compensation decisions, reflecting a governance preference for regular engagement. Investors considering frequency weigh administrative costs and potential for short-termism associated with annual votes against the benefits of regular oversight and quicker corrective feedback loops; for a company with recent equity and financing complexity and operational challenges, annual votes allow shareholders to respond more swiftly to evolving pay-performance dynamics. The Board’s recommendation and intent to consider voting results indicates willingness to be guided by shareholder sentiment but keeps ultimate control. The proxy mechanism allows selection among options, and the outcome is advisory and non-binding, though a clear shareholder preference (e.g., for annual voting) could shape company practice and expectations. For governance analysts, the recommendation for annual votes aligns with a more active shareholder engagement stance and could be seen positively by institutional investors focused on accountability. However, if shareholders select a longer frequency, the company may choose to adopt that cadence or explain reasons for divergence, potentially prompting engagement. Overall, the proposal is low risk procedurally but meaningful as a governance signal about how regularly shareholders can influence executive pay policy.

This management proposal seeks shareholder approval to amend the company’s Certificate of Incorporation to grant the Board discretionary authority to effect a reverse stock split at a ratio between 1-for-15 and 1-for-50. The principal rationale is to provide the Board a tool to address NYSE American listing non-compliance notices tied to stockholders’ equity thresholds and recent reported deficits, as higher per-share prices can help satisfy certain listing standards and make the stock more marketable. The filing explicitly cites notices of non-compliance under Sections 1003(a)(ii) and 1003(a)(i) and a submitted compliance plan with a deadline to regain compliance, framing the split as a defensive, compliance-oriented flexibility rather than a guaranteed cure. The Board emphasizes that implementation would be discretionary and contingent on a determination that a split is in stockholders’ best interests, and that fractional shares would be rounded up (not cashed out), preserving shareholder stakes and conserving cash. The company acknowledges risks including potential liquidity reduction, odd-lot issues, transactional costs, and the possibility that market price may not increase proportionately, and warns of anti-liquidity effects alongside stated benefits for investor perception and eligibility. The proposal also describes adjustments to equity awards and accounting impacts, preserving aggregate economic value of options and reserves while reducing stated capital proportionately. Importantly, approval requires a majority of outstanding shares and broker non-votes count as against, meaning retail participation is material. Given the company’s recent related-party financings and fragile equity position, shareholders should evaluate the Board’s discretion, the chosen wide ratio range, and the rounding-up policy when assessing whether the potential listing and marketability benefits outweigh the liquidity and governance concerns. The Board unanimously recommends FOR, underscoring management’s view that this tool supports compliance and strategic flexibility.

This proposal asks shareholders to approve a charter amendment creating 15,000,000 shares of Class B common stock, each carrying 20 votes per share, to provide management and the Board with flexibility for future capital structure and financing strategies. Management argues the designation enables strategic issuances and financing arrangements supportive of long-term objectives while preserving parity in economic rights aside from enhanced voting power. From a governance perspective, the creation of super-voting shares is material: if issued, Class B shares would concentrate control and could entrench current management or certain holders, reducing influence of existing common stockholders and potentially deterring takeovers or activist interventions. The company notes the amendment alone does not change outstanding common shares or voting power until shares are issued, but explicitly warns of potential anti-takeover effects and dilution of voting influence for common shareholders. The Board retains discretion whether to implement the amendment even if approved, and approvals of this proposal and the reverse split are not interdependent; either may be implemented separately. Institutional investors should evaluate the likelihood of issuance to insiders or affiliates given existing related-party financings and ownership structure (e.g., large Hunniwell stake) and seek clarity on any contemplated issuance plans, transfer restrictions, or sunset provisions. The Board recommends FOR, framing the change as a strategic flexibility tool, but shareholders should weigh the tradeoff between potential financing benefits and the governance risk of concentrated voting power. Given the potential long-term implications, a robust shareholder engagement and clear issuance policy would be prudent if the amendment passes.